Issued Patents 2019
Showing 1–7 of 7 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10478432 | Compositions of matter for treatment of ophthalmic conditions by selectively removing senescent cells from the eye | Remi-Martin Laberge, Marco Demaria, Nathaniel David, Alain P. Vasserot, James L. Kirkland +5 more | 2019-11-19 |
| 10478433 | Unit dose of an aryl sulfonamide that is effective for treating eye disease and averting potential vision loss | Remi-Martin Laberge, Marco Demaria, Nathaniel David, Darren J. Baker, James L. Kirkland +5 more | 2019-11-19 |
| 10328058 | Treating atherosclerosis by removing senescent foam cell macrophages from atherosclerotic plaques | Darren J. Baker, Marco Demaria, Albert Davalos, Bennett G. Childs, Jan M.A. van Deursen +5 more | 2019-06-25 |
| 10328073 | Use of sulfonamide inhibitors of BCL-2 and BCL-xL to treat ophthalmic disease by selectively removing senescent cells | Remi-Martin Laberge, Marco Demaria, Nathaniel David, Alain P. Vasserot, James L. Kirkland +5 more | 2019-06-25 |
| 10279018 | Immunogenic compositions for inducing an immune response for elimination of senescent cells | Alain P. Vasserot, Serge Lichtsteiner | 2019-05-07 |
| 10258618 | Treating pulmonary conditions by selectively removing senescent cells from the lung using an intermittent dosing regimen | Remi-Martin Laberge, Marco Demaria, Nathaniel David, Darren J. Baker, James L. Kirkland +3 more | 2019-04-16 |
| 10213426 | Method of optimizing conditions for selectively removing a plurality of senescent cells from a tissue or a mixed cell population | Remi-Martin Laberge, Albert Davalos, Marco Demaria, Nathaniel David, Yi Zhu +2 more | 2019-02-26 |